Groningen, Netherlands

Hakan V Wikstrom


Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 118(Granted Patents)


Location History:

  • Gothenburg, SE (1988)
  • Goteborg, SE (1984 - 1990)
  • Partille, SE (1986 - 1994)
  • Groningen, SE (1995)
  • NL-9721 WN Groningen, NL (1995)
  • Groningen, NL (1994 - 1997)

Company Filing History:


Years Active: 1984-1997

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Hakan V. Wikstrom: A Pioneer in Central Nervous System Pharmacology

Introduction

Hakan V. Wikstrom is a notable inventor based in Groningen, Netherlands, with a remarkable portfolio of 12 patents. His work primarily focuses on compounds that target the central nervous system, providing innovative solutions for various disorders.

Latest Patents

Wikstrom's recent patents include groundbreaking compounds such as the centrally acting 6,7,8,9-tetrahydro-3H-benz(e) indole heterocyclics, designed for pharmaceutical applications. These compounds have shown potential as 5-HT1A receptor agonists, which could revolutionize treatment options for central nervous system disorders. Another significant patent involves substituted phenylazacycloalkanes, which possess selective properties beneficial for treating conditions such as depression, schizophrenia, and various dysfunctions associated with dopamine receptor activity.

Career Highlights

Throughout his career, Wikstrom has contributed significantly to the pharmaceutical industry, working with prominent companies like The Upjohn Company. His innovations have been recognized for their potential impact on mental health treatment and cognitive function improvement.

Collaborations

Wikstrom has collaborated with esteemed colleagues in the field, such as Per A. Carlsson and Bengt R. Andersson. Their collective efforts have further enhanced the development of innovative pharmaceutical compounds and therapies, pushing the boundaries of neurological treatment methodologies.

Conclusion

Hakan V. Wikstrom stands out as an influential inventor with a commitment to advancing pharmacological solutions for pressing central nervous system disorders. His extensive patent portfolio reflects his dedication to innovation, while his collaborations underscore the importance of teamwork in the realm of scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…